(MedPage Today) — Large database analysis ‘should reassure’
Category: News
Second Sight to Present at the Rodman & Renshaw 18th Annual Global Investment Conference on September 13, 2016
SYLMAR, Calif.–(BUSINESS WIRE)–Second Sight Medical Products, Inc. (NASDAQ:EYES) (“Second Sight” or “the Company”), a developer, manufacturer and marketer of implantable visual prosthetics to provide some useful vision to blind patients, will present at the Rodman & Renshaw 18th Annual Global Investment Conference being held September 11-13, 2016. Second Sight’s Chairman, Dr. Robert Greenberg, will host one-on-one meetings throughout the day on Monday, September 12, 2016 and Tuesday, Sept
Drug Eluting Contact Lenses Treat Glaucoma
Latanoprost (Xalatan) pressure reducing eye drops are the first line of defense against glaucoma. They’re unpleasant enough for a lot of patients to the point that the burning effect leads to poor adherence. What if there were contact lenses that release the drug slowly right onto the eyeball in a precise amount? Well, researchers at Bos (Read more...)
RetroSense Therapeutics Secures Exclusive Worldwide Rights to ReaChR Optogene from the University of California San Diego
ANN ARBOR, Mich.–(BUSINESS WIRE)–RetroSense Therapeutics LLC, a privately-held, clinical-stage biopharmaceutical company, today announced the Company has signed a worldwide license with the University of California San Diego to secure exclusive rights to develop red activatable channelrhodopsin (ReaChR), a next-generation optogene developed by the late Nobel Laureate Roger Y. Tsien, Ph.D. Financial terms were not disclosed. “The ReaChR license allows us to continue building on our world-leadi
Lucas ELENA annonce la création de la société Eyenostics SAS
LA GAUDE, France–(BUSINESS WIRE)–Eyenostics est une société de recherche sous contrat (CRO) dédiée à la recherche et l’analyse de biomarqueurs oculaires. Elle opère dans les études Clinique et Préclinique en utilisant les méthodes de cytométrie de flux et de RT-qPCR. Grâce à ses employés expérimentés, ses partenaires et ses liens avec un consultant de renom, Eyenostics a pour ambition de devenir le partenaire privilégié des laboratoires pharmaceutiques et sociétés de biotechnologie désireux d
Founder & Former CEO of Advantica Eyecare, Richard L. Sanchez, Joins the Argus Dental & Vision, Inc. Leadership Team
TAMPA, Fla.–(BUSINESS WIRE)–Argus Dental & Vision, Inc. announces that Richard L. Sanchez, former CEO and Founder of Advantica Eyecare, has joined the Argus Leadership Team as Executive Vice President of Strategic Alliances.
Laser, Manual Cataract Surgery Equivalent
Compared with manual surgery, the advantages and disadvantages of femtosecond laser-assisted cataract surgery may cancel each other out, a meta-analysis suggests. Medscape Medical News
Drug-dispensing contact lens effectively lowers eye pressure in glaucoma model
A contact lens designed to deliver medication gradually to the eye could improve outcomes for patients with conditions requiring treatment with eye drops, which are often imprecise and difficult to…
‘Internal astigmatism’ doesn’t compensate for changes in the eye over time
For people with nearsightedness (myopia), the lens doesn’t compensate for growth or other changes in the structure of the eye, according to a long-term follow-up study in the September issue of…
New stem-cell model of heart tissue unravels mechanisms linked to hypertrophic cardiomyopathy
Using advanced stem cell technology, scientists from the Icahn School of Medicine at Mount Sinai have created a model of a heart condition called hypertrophic cardiomyopathy (HCM) — an excessive thickening of the heart that is associated with a number of rare and common illnesses, some of which have a strong genetic component.
New stem-cell model of heart tissue unravels mechanisms linked to hypertrophic cardiomyopathy
Using advanced stem cell technology, scientists from the Icahn School of Medicine at Mount Sinai have created a model of a heart condition called hypertrophic cardiomyopathy (HCM) — an excessive thickening of the heart that is associated with a number of rare and common illnesses, some of which have a strong genetic component.
Adalimumab Lowers Risk of Uveitic Flare
Adalimumab reduces the risk of uveitic flare after corticosteroid withdrawal in patients with inactive, noninfectious uveitis, according to results from VISUAL II. Reuters Health Information
Make the Diagnosis: Select the Surgery
(MedPage Today) — Case Findings: Which choice is the correct procedure for the patient’s preoperative condition, based on the image shown?
National Vision Inc. Announces 2016 College Scholarship Recipients
DULUTH, Ga.–(BUSINESS WIRE)–National Vision Inc., one of the nation’s largest optical retailers providing comprehensive, quality, affordable eye care and vision health, is pleased to announce it has selected five outstanding students as recipients of the 2016 National Vision Inc. College Scholarship Program. Recipients will receive $2,500 to fund the advancement of their education. The award is renewable for up to three years for a total scholarship of $10,000 per student. “We are proud to co
$26 Billion Global Ophthalmology Drugs Market to 2022 – Angiogenesis Modulators and Gene Therapies to Boost Overall Revenue within the Forecast Period – Research and Markets
DUBLIN–(BUSINESS WIRE)–Research and Markets has announced the addition of the “Global Ophthalmology Drugs Market to 2022 – Angiogenesis Modulators and Gene Therapies to Boost Overall Revenue within the Forecast Period” report to their offering. Globa…
New test needed to assess the quality and safety of sunglasses
Revision of standards is needed to test sunglasses quality and establish safe limits for the lenses’ UV filters, according to research published in the open access journal Biomedical Engineering…
Penn scientists find striking similarities between human patients with LCA and dogs
Ciliopathies are diseases that affect the cilia, sensory organelles that most mammalian cells possess and which play a critical role in many biological functions.
Novel drug-dispensing contact lens effective in providing better pressure reduction in glaucoma model
A contact lens designed to deliver medication gradually to the eye could improve outcomes for patients with conditions requiring treatment with eye drops, which are often imprecise and difficult to self-administer.
Telemedicine could be more convenient to provide monitoring for diabetic eye care
Electronic eye exams could become popular in the U.S. among patients who see them as an easy way to visit the eye doctor.
Surgical Correction of Presbyopia
This article provides an overview of various newly developed options for the surgical treatment of presbyopia. International Ophthalmology Clinics